NO850536L - Fremgangsmaate for analysering av en proeve med hensyn paa interferon epsilon. - Google Patents

Fremgangsmaate for analysering av en proeve med hensyn paa interferon epsilon.

Info

Publication number
NO850536L
NO850536L NO850536A NO850536A NO850536L NO 850536 L NO850536 L NO 850536L NO 850536 A NO850536 A NO 850536A NO 850536 A NO850536 A NO 850536A NO 850536 L NO850536 L NO 850536L
Authority
NO
Norway
Prior art keywords
interferon
cells
epsilon
stated
sample
Prior art date
Application number
NO850536A
Other languages
English (en)
Norwegian (no)
Inventor
Roy H L Pang
Original Assignee
Damon Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Damon Biotech Inc filed Critical Damon Biotech Inc
Publication of NO850536L publication Critical patent/NO850536L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO850536A 1984-07-06 1985-02-12 Fremgangsmaate for analysering av en proeve med hensyn paa interferon epsilon. NO850536L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/628,612 US4675282A (en) 1984-07-06 1984-07-06 Assay for interferon epsilon

Publications (1)

Publication Number Publication Date
NO850536L true NO850536L (no) 1986-01-07

Family

ID=24519613

Family Applications (1)

Application Number Title Priority Date Filing Date
NO850536A NO850536L (no) 1984-07-06 1985-02-12 Fremgangsmaate for analysering av en proeve med hensyn paa interferon epsilon.

Country Status (14)

Country Link
US (1) US4675282A (da)
JP (1) JPS6125060A (da)
AU (1) AU3857085A (da)
BE (1) BE902663A (da)
CA (1) CA1244345A (da)
CH (1) CH666285A5 (da)
DE (1) DE3515803A1 (da)
DK (1) DK99185A (da)
FR (1) FR2567269A1 (da)
GB (1) GB2161270A (da)
IT (1) IT1183809B (da)
NL (1) NL8501564A (da)
NO (1) NO850536L (da)
SE (1) SE8500620L (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3779909T2 (de) * 1986-03-06 1993-01-07 Commw Scient Ind Res Org In-vitro-testverfahren zum nachweis zellulaerer immunresponsen.
ZA9811070B (en) 1997-12-08 2000-07-03 Genentech Inc Type I interferons.
CA2311681A1 (en) 1997-12-08 1999-06-17 Genentech, Inc. Human interferon-epsilon: a type i interferon
BRPI0507169A (pt) 2004-02-02 2007-06-26 Ambrx Inc polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
SG188143A1 (en) 2008-02-08 2013-03-28 Ambrx Inc Modified leptin polypeptides and their uses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1443425A (en) * 1972-10-25 1976-07-21 Searle & Co Interferon assay
US3910824A (en) * 1973-10-18 1975-10-07 Searle & Co Interferon assay
US4241174A (en) * 1978-11-24 1980-12-23 Hoffmann-La Roche Inc. Interferon assay
JPS56135420A (en) * 1980-03-26 1981-10-22 Fumiaki Taguchi Suppressive substance of virus and its preparation
SE8303925L (sv) * 1982-07-12 1984-01-13 Damon Biotech Inc Interferon e
IL66733A (en) * 1982-09-07 1986-03-31 Yeda Res & Dev Assay for ifn and kit therefor

Also Published As

Publication number Publication date
CA1244345A (en) 1988-11-08
DE3515803A1 (de) 1986-01-16
BE902663A (fr) 1985-09-30
US4675282A (en) 1987-06-23
IT8567398A1 (it) 1986-10-30
NL8501564A (nl) 1986-02-03
GB2161270A (en) 1986-01-08
SE8500620D0 (sv) 1985-02-12
IT8567398A0 (it) 1985-04-30
FR2567269A1 (fr) 1986-01-10
DK99185D0 (da) 1985-03-04
SE8500620L (sv) 1986-01-07
DK99185A (da) 1986-01-07
GB8517164D0 (en) 1985-08-14
AU3857085A (en) 1986-01-09
JPS6125060A (ja) 1986-02-03
CH666285A5 (de) 1988-07-15
IT1183809B (it) 1987-10-22

Similar Documents

Publication Publication Date Title
Hatmal et al. Comprehensive literature review of monkeypox
Chang et al. Physical, morphological, and biochemical alterations in the membrane of AKR mouse cells after interferon treatment.
Hartley et al. Complement fixation and tissue culture assays for mouse leukemia viruses.
Rubin An analysis of the assay of Rous sarcoma cells in vitro by the infective center technique
Evans Cytological methods for detecting chemical mutagens
Zen-Yoji et al. Isolation of Yersinia enterocolitica and Yersinia pseudotuberculosis from swine, cattle and rats at an abattoir
Finter Quantitative haemadsorption, a new assay technique: I. Assay of interferon
Yeh et al. Automated, quantitative cytopathic effect reduction assay for interferon
Bowser et al. Isolation of channel catfish virus from channel catfish, lctalurus punctatus (Rafinesque), broodstock.
Chen et al. Establishing a safe, rapid, convenient and low-cost antiviral assay of interferon bioactivity based on recombinant VSV expressing GFP
Jeney et al. An in vitro technique for surveying immunostimulants in fish
Genovesi et al. Effect of macrophage-specific colony-stimulating factor (CSF-1) on swine monocyte/macrophage susceptibility to in vitro infection by African swine fever virus
US4675282A (en) Assay for interferon epsilon
Potter et al. The incidence of HI antibody to Influenza virus A2/Singapore/1/57 in individuals of blood groups A and O
McClain et al. Plaque morphology and pathogenicity of vesicular exanthema virus
Pearson et al. Immunological and virological investigations on owl monkeys infected with Herpesvirus saimiri
Soldo Cultivation of two strains of killer Paramecium aurelia in axenic medium.
Murphy Jr et al. Differentiation of closely related cells by a variant of poliovirus, type 2, MEF1 strain
Kurta Bat rabies in Michigan
Risley et al. An improved method for cytogenetic analysis of meiotic aneuploidy in rodent and frog spermatocytes
Rossi et al. Factors affecting the assay of bovine type I interferon on bovine embryonic lung cells
Minkin et al. Multiwell chamber chemotaxis assays: improved experimental design and data analysis
Schüler et al. A testudinid herpesvirus 1 (TeHV1)-associated disease outbreak in a group of Horsfield’s tortoises (Testudo horsfieldii)
Chen et al. Failure of extracts from Malassezia pachydermatis to stimulate canine keratinocyte proliferation in vitro
Gamal Elden et al. Virological, Molecular and Immuno-Biochemical Studies of Lumpy Skin Disease in Naturally Infected Cattle